CNC INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

Core Viewpoint - A class action lawsuit has been filed against Centene Corporation for alleged violations of federal securities laws, claiming that the company made materially false and misleading statements regarding its business and operations [1][2]. Group 1: Class Definition - The lawsuit seeks damages on behalf of all individuals and entities that purchased Centene securities between December 12, 2024, and June 30, 2025, inclusive [2]. Group 2: Case Details - The complaint alleges that Centene made false and misleading statements while concealing adverse facts about its enrollment and morbidity rates [3]. - It is claimed that Centene's internal analysis indicated that its 2025 Health Insurance Marketplace growth across 22 states, which represents 72% of its marketplace membership, was significantly below expectations [3]. - As a result of these issues, Centene withdrew its 2025 guidance, reducing projected earnings to approximately $1.8 billion or an adjusted diluted EPS of $2.75 [3]. - Following these disclosures, Centene's stock price fell dramatically by 40.4%, from $56.65 per share on July 1, 2025, to $33.78 per share on July 2, 2025 [3]. Group 3: Next Steps - Investors who suffered losses in Centene have until September 8, 2025, to request to be appointed as lead plaintiff in the class action lawsuit [4].